摘要
目的观察人参皂苷Rg3抗日本血吸虫病肝纤维化的作用和疗效。方法 54只雄性IcR小鼠随机分为健康对照组(A组)、感染对照组(B组)、吡喹酮加人参皂苷Rg3治疗组(C组)和吡喹酮治疗组(D组)等4组,A组18只,其余每组12只。日本血吸虫尾蚴以腹部贴片法经皮肤攻击感染B、C和D组小鼠,每鼠感染尾蚴18-22条。感染后10周,称取各小鼠体重,A、B组小鼠分别取左叶肝组织,于10%甲醛溶液中固定,保存备用。C、D组每鼠吡喹酮一次性灌胃(300 mg/kg)杀虫治疗。吡喹酮治疗次日起,C组每鼠予以人参皂苷Rg3 3 mg/(kg.d)灌胃治疗,连续8周。治疗8周后,处死所有剩余小鼠,在每鼠的左叶肝组织于相同部位取材,石蜡包埋,连续切片(厚度为4μm),进行苏木素-伊红(HE)染色和苦味酸-酸性品红(VG)染色,观察肝组织病理学变化和肝脏内胶原沉积情况。参考《慢性肝炎肝纤维化半定量记分(SSS)方案》,对小鼠肝脏纤维化病变程度进行评分并作统计学分析,以评定人参皂苷Rg3的治疗效果。结果 B组小鼠HE染色发现,肝小叶内和汇管区均可见大量虫卵沉积,有嗜酸性脓肿和假结核结节形成,并以汇管区为重;VG染色发现,肝汇管区和虫卵肉芽肿周围可见明显纤维增生,增生的纤维组织主要沿汇管区分布,形成干线型纤维化,部分纤维呈条索状,向小叶内延伸,形成纤维间隔。C组小鼠经人参皂苷Rg3治疗8周后,肝脏仍有不同程度增大,呈暗褐色,质地略韧;肝脏内纤维增生、炎细胞浸润等病变较B组为轻。C组小鼠肝脏胶原面积百分比为(2.32±0.99)%,低于B组[(11.08±4.43)%]和D组[(11.19±4.91)%](均P〈0.05)。C组小鼠SSS评分(2.83±1.09)显著低于B组(7.42±1.16)和D组(8.08±1.76)(均P〈0.05)。结论吡喹酮治疗后,人参皂苷Rg3具有改善小鼠日本血吸虫病肝纤维化作用。
Objective To investigate the therapeutic efficacy of ginsenoside Rg3 on hepatic fibrosis in murine schistosomiasis japonica.Methods 54 ICR-strain male mice were divided into 4 groups named as normal control group(A),infected control group(B),praziquantel+Rg3 treated group(C) and praziquantel treated group(D).There were 12 mice in each group,but 18 in group A.Mice in groups B,C,and D were infected with 20±2 cercariae of Schistosoma japonicum.At ten weeks post-infection,10 mice of group A and 12 mice of group B were weighed and sacrificed.Specimens from left hepatic lobes were taken and fixed in 10% formaldehyde solution.Mice in groups C and D were treated intragastrically with praziquantel at a single dose of 300 mg/kg.At the second day after praziquantel treatment,each mouse in group C was given 3 mg/(kg·d) ginsenoside Rg3 for 8 weeks.The rest mice were sacrificed on 8 weeks after treatment,and liver tissue samples from left hepatic lobes were prepared.The histological changes and collagen fiber deposition in the liver tissue sections were observed with hematoxylin-eosin staining and van gieson staining.Liver fibrosis was graded according to semi-quantitative scoring system(SSS) method.Results In group B,many eggs deposited in the hepatic lobules and portal areas,and eosinophilic abscesses and pseudo-tubercles developed in the liver,especially common in portal areas.There were many fibre hyperplasia and deposit inside abbacy and liver flocculus.Pipestem fibrosis formed around the portal areas,and some cord-like fibres extended into hepatic lobules,and formed in the fibrous septa.After 8-week treatment with ginsenoside Rg3,in group C,the livers were initially enlarged,firm and dust-color;and the degree of hepatomegly varied from mild to marked;but the degree of fibre hyperplasia and inflammatory infiltration were mitigated compared with that of group B.Mean percentage of collagen area in group C[(2.32±0.99)%] was lower than that of groups B [(11.08±4.43)%] and D [(11.19±4.91)%](P0.05).The SSS scores of hepatic fibrosis in group C(2.83±1.09) was lower than that of groups B(7.42±1.16) and D(8.08±1.76)(P0.05).Conclusion Ginsenoside Rg3 shows anti-hepatofibrosis effects in murine schistosomiasis japonica after praziquantel treatment.
出处
《中国寄生虫学与寄生虫病杂志》
CAS
CSCD
北大核心
2011年第2期107-110,共4页
Chinese Journal of Parasitology and Parasitic Diseases
关键词
血吸虫病
肝纤维化
人参皂苷RG3
Schistosomiasis japonica
Hepatic fibrosis
Ginsenoside Rg3